Showing results (451-460 of 522) with videos related to
Sort By:
Pageof 53
Annals of Neurology|September 11, 1999
The neurological manifestations of Nipah virus encephalitis, a novel paramyxovirusK E Lee, T Umapathi, C B Tan, et al.Journal of General Internal Medicine|September 19, 2023
What Went Right? A Mixed-Methods Study of Positive Feedback Data in a Hospital-Wide Mortality Review SurveyIsaac S Chua, Roaa M Khinkar, Matthew Wien, et al.Journal of Pain and Symptom Management|August 19, 2022
Video and In-Person Palliative Care Delivery Challenges before and during the COVID-19 PandemicIsaac S Chua, Molly Olmsted, Rachel Plotke, et al.Endoscopy International Open|November 18, 2021
Hybrid endoscopic mucosal resection and full-thickness resection for large colonic polyps harboring a small focus of invasive cancer: a case seriesJamie S Chua, Hao Dang, Liselotte W Zwager, et al.The Journal of Surgical Research|March 7, 2018
Computed tomography in ventral hernia diagnosis: have we improved? A quality improvement initiativeJulie L Holihan, Deepa Cherla, Katherine J Blair, et al.Digestive Diseases and Sciences|November 27, 2014
Autoimmunity Links Vinculin to the Pathophysiology of Chronic Functional Bowel Changes Following Campylobacter jejuni Infection in a Rat ModelMark Pimentel, Walter Morales, Venkata Pokkunuri, et al.PHAGE (New Rochelle, N.Y.)|June 23, 2023
"Two Is Better Than One": The Multifactorial Nature of Phage-Antibiotic Combinatorial Treatments Against ESKAPE-Induced InfectionsGale Bernice N Fungo, John Christian W Uy, Kristiana Louise J Porciuncula, et al.Plos One|May 14, 2015
Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjectsMark Pimentel, Walter Morales, Ali Rezaie, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|April 29, 2016
Detection of Drug-Induced Acute Kidney Injury in Humans Using Urinary KIM-1, miR-21, -200c, and -423Mira Pavkovic, Cassianne Robinson-Cohen, Alicia S Chua, et al.Cancers|February 11, 2023
SAINT: A Phase I/Expanded Phase II Study Using Safe Amounts of Ipilimumab, Nivolumab and Trabectedin as First-Line Treatment of Advanced Soft Tissue SarcomaErlinda Maria Gordon, Sant P Chawla, Walter Andree Tellez, et al.Pageof 53